Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Lung/Thoracic Oncology

Genetic damage in lymphocytes of lung cancer patients is correlated to the composition of the respiratory tract microbiome

Mutagenesis | Jan 20, 2021 Lung/Thoracic Oncology

Evaluation of Hippo pathway and CD133 in radiation resistance in small-cell lung cancer

Journal of Oncology | Jan 20, 2021 Lung/Thoracic Oncology

Combination of immune checkpoint inhibitors and radiotherapy for advanced non- small-cell lung cancer and prostate cancer: A meta-analysis

Journal of Oncology | Jan 20, 2021 Lung/Thoracic Oncology

Updated overall survival and PD-L1 subgroup analysis of patients with extensive-stage small-cell lung cancer treated with atezolizumab, carboplatin, and etoposide (IMpower133)

Journal of Clinical Oncology | Jan 19, 2021 Lung/Thoracic Oncology

Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial

Lung Cancer | Jan 18, 2021 Lung/Thoracic Oncology

Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study

Lung Cancer | Jan 18, 2021 Lung/Thoracic Oncology

Use of ACE (angiotensin-converting enzyme) inhibitors and risk of lung cancer

Circulation: Cardiovascular Quality and Outcomes | Jan 17, 2021 Lung/Thoracic Oncology

Uptake and survival effects of minimally invasive surgery for lung cancer: A population-based study

European Journal of Surgical Oncology | Jan 15, 2021 Lung/Thoracic Oncology

Stage-specific PET radiomic prediction model for the histological subtype classification of non-small-cell lung cancer

Cancer Management and Research | Jan 15, 2021 Lung/Thoracic Oncology

Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC)

Lung Cancer | Jan 14, 2021 Lung/Thoracic Oncology

« Prev 1 … 21 22 23 24 25 … 149 Next »

Genetic damage in lymphocytes of lung cancer patients is correlated to the composition of the respiratory tract microbiome

Evaluation of Hippo pathway and CD133 in radiation resistance in small-cell lung cancer

Combination of immune checkpoint inhibitors and radiotherapy for advanced non- small-cell lung cancer and prostate cancer: A meta-analysis

Updated overall survival and PD-L1 subgroup analysis of patients with extensive-stage small-cell lung cancer treated with atezolizumab, carboplatin, and etoposide (IMpower133)

Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial

Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study

Use of ACE (angiotensin-converting enzyme) inhibitors and risk of lung cancer

Uptake and survival effects of minimally invasive surgery for lung cancer: A population-based study

Stage-specific PET radiomic prediction model for the histological subtype classification of non-small-cell lung cancer

Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC)

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Genetic damage in lymphocytes of lung cancer patients is correlated to the composition of the respiratory tract microbiome

Evaluation of Hippo pathway and CD133 in radiation resistance in small-cell lung cancer

Combination of immune checkpoint inhibitors and radiotherapy for advanced non- small-cell lung cancer and prostate cancer: A meta-analysis

Updated overall survival and PD-L1 subgroup analysis of patients with extensive-stage small-cell lung cancer treated with atezolizumab, carboplatin, and etoposide (IMpower133)

Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial

Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study

Use of ACE (angiotensin-converting enzyme) inhibitors and risk of lung cancer

Uptake and survival effects of minimally invasive surgery for lung cancer: A population-based study

Stage-specific PET radiomic prediction model for the histological subtype classification of non-small-cell lung cancer

Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC)

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic